cepharanthine has been researched along with Autoimmune Thrombocytopenia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagai, T; Tabata, C; Tabata, R; Tazoh, A | 1 |
| Endo, T; Fujimoto, K; Hashino, S; Imamura, M; Iwasaki, H; Kobayashi, N; Kohda, K; Kurosawa, M; Maekawa, I; Miyagishima, T; Miyake, T; Sasagawa, H; Takahata, M; Tanaka, J; Teshima, T; Tsustumi, Y | 1 |
| Fukuroi, T; Kagawa, H; Kawakatsu, T; Kido, H; Miyake, T; Miyazaki, Y; Nomura, S; Suzuki, M; Yamaguchi, K; Yanabu, M | 1 |
| Hirai, K; Kohgo, Y; Onodera, R; Saito, N; Takemori, N; Watanabe, S | 1 |
| Fukuhara, S; Kagawa, H; Matsuzaki, T; Nagahama, M; Nakayama, S; Nomura, S; Ozaki, Y; Yamaoka, M; Yoshimura, C | 1 |
| Fujita, H; Kimishima, A; Morita, I; Murota, S; Ono, M; Sato, T; Tomiyama, J | 1 |
1 review(s) available for cepharanthine and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma.
Topics: Aged; Benzylisoquinolines; Humans; Immunoglobulin G; Male; Melphalan; Multiple Myeloma; Platelet Count; Prednisolone; Purpura, Thrombocytopenic, Idiopathic | 2012 |
5 other study(ies) available for cepharanthine and Autoimmune Thrombocytopenia
| Article | Year |
|---|---|
[Clinical efficacy of high-dose cepharanthine for idiopathic thrombocytopenic purpura: retrospective multicenter analysis].
Topics: Adult; Aged; Aged, 80 and over; Benzylisoquinolines; Humans; Middle Aged; Platelet Count; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies; Treatment Outcome; Young Adult | 2012 |
Effect of cepharanthin and cytochalasin D on platelet internalization of anti-glycoprotein IIb/IIIa antibodies.
Topics: Alkaloids; Autoantibodies; Benzylisoquinolines; Blood Platelets; Cytochalasin D; Flow Cytometry; Humans; Platelet Membrane Glycoproteins; Purpura, Thrombocytopenic, Idiopathic | 1994 |
High-dose biscoclaurine alkaloids together with prednisolone raise platelet counts in chronic idiopathic thrombocytopenic purpura.
Topics: Alkaloids; Anti-Inflammatory Agents, Non-Steroidal; Benzylisoquinolines; Chronic Disease; Drug Therapy, Combination; Humans; Platelet Count; Prednisolone; Purpura, Thrombocytopenic, Idiopathic | 1996 |
Genetic analysis of HLA- and HPA-typing in idiopathic (autoimmune) thrombocytopenic purpura patients treated with cepharanthin.
Topics: Adult; Aged; Alkaloids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Human Platelet; Autoantigens; Autoimmune Diseases; Benzylisoquinolines; Blood Platelets; Combined Modality Therapy; Drug Resistance; Endocytosis; Female; Genetic Predisposition to Disease; Genotype; HLA Antigens; HLA-DQ Antigens; HLA-DQ beta-Chains; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Male; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Polymorphism, Single-Stranded Conformational; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; Treatment Outcome | 1999 |
Pharmacological characterization of cepharanthin in chronic idiopathic thrombocytopenic purpura.
Topics: Alkaloids; Animals; Antigens, CD34; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Blood Cell Count; Chronic Disease; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Interleukin-3; Interleukin-6; Male; Megakaryocytes; Mice; Mice, Inbred Strains; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Thrombopoietin | 2001 |